EP3801552A4 - Composition et procédé d'inhalation - Google Patents

Composition et procédé d'inhalation Download PDF

Info

Publication number
EP3801552A4
EP3801552A4 EP19815062.5A EP19815062A EP3801552A4 EP 3801552 A4 EP3801552 A4 EP 3801552A4 EP 19815062 A EP19815062 A EP 19815062A EP 3801552 A4 EP3801552 A4 EP 3801552A4
Authority
EP
European Patent Office
Prior art keywords
inhalation
composition
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
EP19815062.5A
Other languages
German (de)
English (en)
Other versions
EP3801552A1 (fr
Inventor
Joseph J. Guarneri
Nikhil AMIN
Marshall L. Grant
John J. Freeman
Kelly S. Kraft
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Mannkind Corp
Original Assignee
Mannkind Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Mannkind Corp filed Critical Mannkind Corp
Publication of EP3801552A1 publication Critical patent/EP3801552A1/fr
Publication of EP3801552A4 publication Critical patent/EP3801552A4/fr
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/0075—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy for inhalation via a dry powder inhaler [DPI], e.g. comprising micronized drug mixed with lactose carrier particles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/557—Eicosanoids, e.g. leukotrienes or prostaglandins
    • A61K31/5575—Eicosanoids, e.g. leukotrienes or prostaglandins having a cyclopentane, e.g. prostaglandin E2, prostaglandin F2-alpha
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1617—Organic compounds, e.g. phospholipids, fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1617—Organic compounds, e.g. phospholipids, fats
    • A61K9/1623—Sugars or sugar alcohols, e.g. lactose; Derivatives thereof; Homeopathic globules
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M15/00—Inhalators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2202/00—Special media to be introduced, removed or treated
    • A61M2202/06—Solids
    • A61M2202/064—Powder
EP19815062.5A 2018-06-07 2019-06-07 Composition et procédé d'inhalation Pending EP3801552A4 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201862682109P 2018-06-07 2018-06-07
PCT/US2019/036095 WO2019237028A1 (fr) 2018-06-07 2019-06-07 Composition et procédé d'inhalation

Publications (2)

Publication Number Publication Date
EP3801552A1 EP3801552A1 (fr) 2021-04-14
EP3801552A4 true EP3801552A4 (fr) 2022-02-23

Family

ID=68770678

Family Applications (1)

Application Number Title Priority Date Filing Date
EP19815062.5A Pending EP3801552A4 (fr) 2018-06-07 2019-06-07 Composition et procédé d'inhalation

Country Status (5)

Country Link
EP (1) EP3801552A4 (fr)
JP (1) JP2021527058A (fr)
AU (1) AU2019282808A1 (fr)
CA (1) CA3102967A1 (fr)
WO (1) WO2019237028A1 (fr)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2015061720A2 (fr) 2013-10-25 2015-04-30 Insmed Incorporated Composés de prostacycline, compositions en contenant et leurs procédés d'utilisation
IL310250A (en) 2016-05-05 2024-03-01 Liquidia Tech Inc Terfostinil in dry powder form for the treatment of pulmonary hypertension
WO2020223237A1 (fr) 2019-04-29 2020-11-05 Insmed Incorporated Compositions de poudre sèche de promédicaments de tréprostinil et méthodes d'utilisation de celles-ci
JP2023523557A (ja) 2020-04-17 2023-06-06 ユナイテッド セラピューティクス コーポレイション 間質性肺疾患の治療における使用のためのトレプロスチニル
US11793780B2 (en) 2020-06-09 2023-10-24 United Therapeutics Corporation Prodrugs of treprosiinil
EP4236934A1 (fr) * 2020-10-28 2023-09-06 Insmed Incorporated Compositions de poudre sèche de promédicaments de tréprostinil et procédés d'utilisation associés
CA3199324A1 (fr) 2020-11-17 2022-05-27 Adam Marc Silverstein Imatinib inhale pour le domaine de l'hypertension pulmonaire
EP4301372A1 (fr) 2021-03-03 2024-01-10 United Therapeutics Corporation Composition de poudre sèche de treprostinil et son promédicament et comprenant en outre de l'(e)-3,6-bis[4-(n-carbonyl-2-propényl)amidobutyl]-2,5-dicétopipérazine (fdkp)
US20230263807A1 (en) 2022-02-08 2023-08-24 United Therapeutics Corporation Treprostinil iloprost combination therapy

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20140199398A1 (en) * 2011-06-17 2014-07-17 Mannkind Corporation High capacity diektopiperazine microparticles and methods

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5352461A (en) * 1992-03-11 1994-10-04 Pharmaceutical Discovery Corporation Self assembling diketopiperazine drug delivery system
AU2006290870B2 (en) * 2005-09-14 2013-02-28 Mannkind Corporation Method of drug formulation based on increasing the affinity of active agents for crystalline microparticle surfaces
BR112015023168B1 (pt) * 2013-03-15 2021-08-10 Mannkind Corporation Composição de 3,6-bis(n-fumaril-4-aminobutil)-2,5-dicetopiperazina cristalina, método de produção de partículas de 3,6-bis(n-fumaril-4-aminobutil)-2,5-dicetopiperazina e uso de uma composição de dicetopiperazina cristalina
CN114904100A (zh) * 2016-01-29 2022-08-16 曼金德公司 干粉吸入器
IL310250A (en) * 2016-05-05 2024-03-01 Liquidia Tech Inc Terfostinil in dry powder form for the treatment of pulmonary hypertension

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20140199398A1 (en) * 2011-06-17 2014-07-17 Mannkind Corporation High capacity diektopiperazine microparticles and methods

Also Published As

Publication number Publication date
CA3102967A1 (fr) 2019-12-12
EP3801552A1 (fr) 2021-04-14
AU2019282808A1 (en) 2021-01-07
WO2019237028A1 (fr) 2019-12-12
JP2021527058A (ja) 2021-10-11

Similar Documents

Publication Publication Date Title
EP3816150A4 (fr) Composé m-diamide, son procédé de préparation et son utilisation
EP3864152A4 (fr) Procédés et compositions pour éditer des arn
EP3869985A4 (fr) Composition et méthode pour traiter les poumons
EP3801552A4 (fr) Composition et procédé d'inhalation
EP3626803A4 (fr) Composition et procédé de production d'une composition
EP3752231A4 (fr) Procédé et inhalateur pour fournir au moins deux substances par inhalation
EP3612215A4 (fr) Compositions et procédés pour le traitement d'inflammation pulmonaire
EP3704227A4 (fr) Composition et procédé
GB201905559D0 (en) Composition and method
EP3733650A4 (fr) Procédé de préparation d'un intermédiaire d'élagolix et composition associée
EP3770268A4 (fr) MÉTHODE DE PRODUCTION DE ß-NMN ET COMPOSITION EN CONTENANT
EP3817734A4 (fr) Composition et méthode pour un usage modéré des opioïdes
EP3590361A4 (fr) Composition contenant de la lutéoline et son procédé de fabrication
EP3838890A4 (fr) Procédé de préparation de 18f-bpa et d'un intermédiaire
EP3773520A4 (fr) Particules de bioxomes, redoxomes, procédé et composition
GB201909542D0 (en) Composition and method
EP3664604A4 (fr) Composition herbicide et procédé
EP3685845A4 (fr) Composition et son procédé de production
EP3559115A4 (fr) Composition et procédé de production de la composition
EP3930862A4 (fr) Composition et procédés de fabrication de grips
EP3590360A4 (fr) Composition contenant de la lutéine et procédé pour la produire
EP3891179A4 (fr) Méthodes et compositions pour le traitement de l'asthme
EP3714948A4 (fr) Composition génératrice d'azote pour extinction d'incendies et procédé de production
GB2579687B (en) Composition and method
GB201914777D0 (en) Composition and method

Legal Events

Date Code Title Description
STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE INTERNATIONAL PUBLICATION HAS BEEN MADE

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE INTERNATIONAL PUBLICATION HAS BEEN MADE

PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: REQUEST FOR EXAMINATION WAS MADE

17P Request for examination filed

Effective date: 20201214

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR

AX Request for extension of the european patent

Extension state: BA ME

DAV Request for validation of the european patent (deleted)
DAX Request for extension of the european patent (deleted)
REG Reference to a national code

Ref country code: HK

Ref legal event code: DE

Ref document number: 40049543

Country of ref document: HK

A4 Supplementary search report drawn up and despatched

Effective date: 20220124

RIC1 Information provided on ipc code assigned before grant

Ipc: A61M 15/00 20060101ALI20220118BHEP

Ipc: A61K 31/5575 20060101ALI20220118BHEP

Ipc: A61K 9/16 20060101ALI20220118BHEP

Ipc: A61K 9/48 20060101ALI20220118BHEP

Ipc: A61K 9/00 20060101ALI20220118BHEP

Ipc: A61K 31/557 20060101AFI20220118BHEP

P01 Opt-out of the competence of the unified patent court (upc) registered

Effective date: 20230506

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: EXAMINATION IS IN PROGRESS

17Q First examination report despatched

Effective date: 20240131